Shares Magazine
271.00p-8.00 (-2.87%)08 Nov 2024, 18:10
Jump to:
Maxcyte INC Fundamentals
| Company Name | Maxcyte INC | Last Updated | 2024-11-08 |
|---|---|---|---|
| Industry | Medical Devices | Sector | Healthcare |
| Shares in Issue | 105.089 m | Market Cap | £284.79 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -$0.37 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.0737 | Debt Equity Ratio | 0.0798 |
| Asset Equity Ratio | 1.1366 | Cash Equity Ratio | 0.7111 |
| Quick Ratio | 13.1903 | Current Ratio | 14.31 |
| Price To Book Value | 1.7709 | ROCE | 0 |
Maxcyte INC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Maxcyte INC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | $34.75 m | $33.58 m | $13.37 m |
| Intangible Assets | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | $78.08 m | $34.39 m | $13.69 m |
| Stocks | $12.23 m | $8.58 m | $5.20 m |
| Debtors | 0 | 0 | 0 |
| Cash & Equivalents | $168.29 m | $227.34 m | $255.04 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | $268.27 m | $286.65 m | $284.12 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | $17.86 m | $15.43 m | $15.62 m |
| Creditors after 1 year | $18.25 m | $17.26 m | $5.61 m |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | $36.11 m | $32.69 m | $21.22 m |
| Net assets | $232.17 m | $253.97 m | $262.90 m |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | $1.04 m | $1.02 m | $1.01 m |
| Share Premium | $406.93 m | $390.82 m | $376.19 m |
| Profit / Loss | -$37.92 m | -$23.57 m | -$19.08 m |
| Other Equity | $232.17 m | $253.97 m | $262.90 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | $232.17 m | $253.97 m | $262.90 m |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | $0.07 | $0.06 | $0.02 |
| Debt-to-Equity | $0.08 | $0.06 | $0.02 |
| Assets / Equity | 1.1366 | 1.1366 | 1.1366 |
| Cash / Equity | 0.7111 | 0.7111 | 0.7111 |
| EPS | -$0.37 | -$0.23 | -$0.21 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | -$21.69 m | -$14.78 m | -$10.68 m |
| Cashflow before financing | -$19.54 m | -$11.89 m | $224.04 m |
| Increase in Cash | $35.44 m | -$36.72 m | $29.03 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | $41.29 m | $44.26 m | $33.89 m |
| Cost of sales | $4.74 m | $5.10 m | $3.65 m |
| Gross Profit | $36.55 m | $39.16 m | $30.25 m |
| Operating Profit | -$48.30 m | -$27.36 m | -$18.19 m |
| Pre-Tax profit | -$37.92 m | -$23.57 m | -$19.08 m |
Maxcyte INC Company Background
| Sector | Healthcare |
|---|---|
| Activities | MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies. |
| Latest Interim Date | 6 Aug 2024 |
| Latest Fiscal Year End Date | 12 Mar 2024 |
Maxcyte INC Directors
| Appointed | Name | Position |
|---|---|---|
| 2024-10-18 | Ms. Cynthia Lynne Collins | Director |
| 2024-03-19 | Mr. Douglas J Swirsky | CHIEF FINANCIAL OFFICER |
| 2024-11-06 | Mr. Stanley Charles Erck | Non-Executive Director |
| 2024-06-14 | Mr. Patrick J Balthrop Sr | Non-Executive Director |
| 2024-06-14 | Dr. Richard H. Douglas, PhD | Non-Executive Director |
| 2024-06-14 | Mr. Arthur Michael Mandell | Non-Executive Director |
| 2024-10-31 | Mr. John Joseph Johnston | Non-Executive Director |
| 2024-06-14 | Dr. Yasir B. Al-Wakeel | Non-Executive Director |
| 2023-12-28 | Mr. Douglas Arthur Doerfler | Executive Director,President and Chief Executive Officer |
| 2024-06-14 | Mr. William Wade Brooke | Non-Executive Director |
| 2024-06-14 | Ms. Rekha Hemrajani, M.B.A. | Non-Executive Director |
| 2022-03-29 | Ms. Amanda L. Murphy | Chief Financial Officer |
| 2024-08-05 | Mr. Thomas M. Ross | EVP, GLOBAL SALES |
| 2024-06-11 | Mr. Maher Masoud | Executive Director,President and Chief Executive Officer |
| 2023-03-21 | Mr. Cenk Sumen | Chief Scientific Officer |
| 2024-03-19 | Mr. David I. Sandoval | GENERAL COUNSEL |
| 2024-09-18 | Mr. Ali Soleymannezhad | Chief Commercial Officer |
Maxcyte INC Contact Details
| Company Name | MaxCyte Inc |
|---|---|
| Address | 22 Firstfield Road, Suite 110, Gaithersburg, 20878 |
| Telephone | +1 301 944-1700 |
| Website | https://www.maxcyte.com |
Maxcyte INC Advisors
| Registrar | Capita Asset Services |
|---|---|
| Phone | +44 1534847000 |
| Fax | +44 1534847001 |
| Auditor | Aronson LLC |
|---|---|
| Phone | +1 301 231-6200 |
| Fax | +1 301 231-7630 |
| Solicitor | Cooley LLP |
|---|---|
| Phone | +1 703 456-8000 |
| Financial PR Adviser | Consilium Strategic Communications |
|---|---|
| Phone | +44 2037095700 |
| Solicitor | Feldhaus Law Group, P.C. |
|---|
| Solicitor | Travers Smith LLP |
|---|---|
| Phone | +44 2072953000 |
| Fax | +44 2072953500 |
| Solicitor | Norton Rose Fulbright US LLP |
|---|
| Nominated Adviser | Panmure Gordon (UK) Ltd |
|---|---|
| Phone | +44 2078862500 |
| Stockbroker | Panmure Gordon (UK) Ltd |
|---|---|
| Phone | +44 2078862500 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Wood Group (John) PLC | 57.85 | 16.07 |
| Wizz Air Holdings PLC | 1,517.00 | 10.25 |
| International Consolidated Airlines Group S.A. | 234.50 | 7.18 |
| Endeavour Mining PLC | 1,669.00 | 4.25 |
| Lancashire Holdings Limited | 682.00 | 3.49 |
| Intercontinental Hotels Group PLC | 9,258.00 | 2.78 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Vistry Group PLC | 738.00 | -15.51 |
| Mitie Group PLC | 107.20 | -10.07 |
| Serco Group PLC | 160.00 | -9.81 |
| Mitchells & Butlers PLC | 233.00 | -7.72 |
| Burberry Group PLC | 804.80 | -7.56 |
| Antofagasta PLC | 1,689.00 | -6.61 |
Risers/fallers data from previous trading day.